These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20224393)

  • 1. Myocardial scar as arrhythmia risk in patients with hypertrophic cardiomyopathy.
    Amado LC; Lima JA
    Curr Opin Cardiol; 2010 May; 25(3):276-81. PubMed ID: 20224393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incremental value of late gadolinium enhancement for management of patients with hypertrophic cardiomyopathy.
    Greulich S; Schumm J; Grün S; Bruder O; Sechtem U; Mahrholdt H
    Am J Cardiol; 2012 Oct; 110(8):1207-12. PubMed ID: 22762717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
    Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI of hypertrophic cardiomyopathy: part 2, Differential diagnosis, risk stratification, and posttreatment MRI appearances.
    Hansen MW; Merchant N
    AJR Am J Roentgenol; 2007 Dec; 189(6):1344-52. PubMed ID: 18029870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy.
    Nojiri A; Hongo K; Kawai M; Komukai K; Sakuma T; Taniguchi I; Yoshimura M
    J Cardiol; 2011 Nov; 58(3):253-60. PubMed ID: 21890327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial fibrosis evaluated by Look-Locker and late gadolinium enhancement magnetic resonance imaging in apical hypertrophic cardiomyopathy: association with ventricular tachyarrhythmia and risk factors.
    Amano Y; Takeda M; Tachi M; Kitamura M; Kumita S
    J Magn Reson Imaging; 2014 Aug; 40(2):407-12. PubMed ID: 24924216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging of hypertrophic cardiomyopathy.
    Cannavale A; Ordovás KG; Higgins CB
    J Thorac Imaging; 2013 Jan; 28(1):W12-8. PubMed ID: 20827222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging.
    Gao P; Yee R; Gula L; Krahn AD; Skanes A; Leong-Sit P; Klein GJ; Stirrat J; Fine N; Pallaveshi L; Wisenberg G; Thompson TR; Prato F; Drangova M; White JA
    Circ Cardiovasc Imaging; 2012 Jul; 5(4):448-56. PubMed ID: 22572740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial tissue characterization by gadolinium-enhanced cardiac magnetic resonance imaging for risk stratification of adverse events in hypertrophic cardiomyopathy.
    Raiker N; Vullaganti S; Collins JD; Allen BD; Choudhury L
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1147-1156. PubMed ID: 32166506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Association between delayed enhancement on cardiac magnetic resonance imaging and arrhythmia in patients with hypertrophic cardiomyopathy].
    WANG J; KONG XQ; XU HB; ZHOU GF; LIU F; SHI HJ; LIU DX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):775-80. PubMed ID: 21092642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of cardiovascular MRI for risk stratification in hypertrophic cardiomyopathy.
    Hoey ET; Teoh JK; Das I; Ganeshan A; Simpson H; Watkin RW
    Clin Radiol; 2014 Mar; 69(3):221-30. PubMed ID: 24412355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial scar detected by contrast-enhanced cardiac magnetic resonance imaging is associated with ventricular tachycardia in hypertrophic cardiomyopathy patients.
    Suk T; Edwards C; Hart H; Christiansen JP
    Heart Lung Circ; 2008 Oct; 17(5):370-4. PubMed ID: 18562248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside.
    Bogaert J; Olivotto I
    Radiology; 2014 Nov; 273(2):329-48. PubMed ID: 25340269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy.
    Miller MA; Gomes JA; Fuster V
    Nat Clin Pract Cardiovasc Med; 2007 Dec; 4(12):667-76. PubMed ID: 18033231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.
    O'Hanlon R; Grasso A; Roughton M; Moon JC; Clark S; Wage R; Webb J; Kulkarni M; Dawson D; Sulaibeekh L; Chandrasekaran B; Bucciarelli-Ducci C; Pasquale F; Cowie MR; McKenna WJ; Sheppard MN; Elliott PM; Pennell DJ; Prasad SK
    J Am Coll Cardiol; 2010 Sep; 56(11):867-74. PubMed ID: 20688032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
    Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W
    Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced myocardial T1-weighted scout (Look-Locker) imaging for the detection of myocardial damages in hypertrophic cardiomyopathy.
    Amano Y; Takayama M; Kumita S
    J Magn Reson Imaging; 2009 Oct; 30(4):778-84. PubMed ID: 19787718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging for hypertrophic cardiomyopathy update.
    Chan AK; Somarouthu B; Ghoshhajra B
    Top Magn Reson Imaging; 2014 Feb; 23(1):33-41. PubMed ID: 24509622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI of hypertrophic cardiomyopathy: part I, MRI appearances.
    Hansen MW; Merchant N
    AJR Am J Roentgenol; 2007 Dec; 189(6):1335-43. PubMed ID: 18029869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.